Summary
Stryker Corporation (SYK) announced on March 7, 2016, that it entered into an Underwriting Agreement to issue and sell debt securities in a public offering. This offering is expected to generate approximately $3.453 billion in net proceeds. The company has outlined specific uses for these funds, primarily to finance two significant previously announced acquisitions: Sage Products Holdings II, LLC and Physio-Control International, Inc. The debt issuance includes four tranches of notes with varying interest rates and maturity dates, ranging from March 2019 to March 2046. The proceeds are critical for completing these strategic acquisitions, which are expected to enhance Stryker's market position and product portfolio. The offering is not contingent on the successful closing of these acquisitions, indicating Stryker's commitment to pursuing these strategic moves.
Key Highlights
- 1Stryker Corporation is issuing new debt securities in an underwritten public offering.
- 2The offering is expected to raise approximately $3.453 billion in net proceeds.
- 3The majority of the proceeds ($2.775 billion) are earmarked for the acquisition of Sage Products Holdings II, LLC.
- 4Remaining proceeds will fund the acquisition of Physio-Control International, Inc., repay existing debt, and for general corporate purposes.
- 5The debt issuance comprises four tranches of notes with principal amounts totaling $3.75 billion.
- 6Interest rates on the new notes range from 2.000% to 4.625%, with maturities from 2019 to 2046.
- 7The offering is being conducted under Stryker's Automatic Shelf Registration Statement on Form S-3.